Prescription Medications

Herbal Supplement Might Prevent Prostate Cancer

Zyflamend, which is commonly used as an anti-inflammatory, may prove effective in preventing prostate cancer. Prostatic intraepithelial neoplasia (PIN) is a clinical precursor to prostrate cancer. Without intervention, men with PIN have a 50 percent to 70 percent risk of developing prostate cancer, the researchers said.

"Zyflamend has shown an ability, in vitro, to reduce prostate cancer cell proliferation by as much as 78 percent and to induce cancer cell death or apoptosis," principal investigator Dr. Aaron E. Katz, an associate professor of urology and director of the Center of Holistic Urology at Columbia, said in a prepared statement.

"These results are exceptionally promising and have led us to initiate this clinical trial," Katz said.